Comparison of18F-fluoride PET/CT, 18F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: A pilot study

British Journal of Radiology

Volumn 87, Issue 1034, 2014, Pages

  Ota, Naotoshi ^a,b   Kato, Katsuhiko ^a   Iwano, Shingo ^a   Ito, Shinji ^a   Abe, Shinji ^c   Fujita, Naotoshi ^c   Yamashiro, Keiichi ^c   Yamamoto, Seiichi ^a   Naganawa, Shinji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; MEDRONATE TECHNETIUM TC 99M; OXIDRONATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BONE; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; GAMMA CAMERA; HORMONE SUBSTITUTION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PET SCANNER; PILOT STUDY; PLANAR BONE SCINTIGRAPHY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER; THYROIDECTOMY; WHOLE BODY IMAGING; ADENOCARCINOMA; BONE TUMOR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODAL IMAGING; PAPILLARY CARCINOMA; RADIOGRAPHY; SCINTISCANNING; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; AGED; BONE AND BONES; BONE NEOPLASMS; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROIDECTOMY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893411842     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20130444     Document Type: Article

References (18)

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306. doi: 10.1056/NEJM199801293380506 (Pubitemid 28065257)
2. Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 2003; 197: 191-7. doi: 10.1016/S1072-7515(03)00332-6 (Pubitemid 36927381)
3. Jacobson AF. Bone scanning in metastatic disease. In: Collier BD Jr, Fogelman I, Rosenthall L, eds. Skeletal Nuclear Medicine. St. Louis, MO: Mosby; 1996. pp. 87-123.
4. Kosuda S, Tatsumi K, Yokoyama H, Yokokawa T, Katayama M, Iriye T, et al. Does bone SPECT actually have lower sensitivity for detecting vertebral metastases than MRI? J Nucl Med 1996; 37: 975-8. (Pubitemid 126447133)
5. Roland J, van den Weygaert D, Krug B, Brans B, Scalliet P, Vandevivere J. Metastases seen on SPECT imaging despite a normal planar bone scan. Clin Nucl Med 1995; 20: 1052-4.
6. Sedonja I, Budihna NV. The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine. Clin Nucl Med 1999; 24: 407-13. (Pubitemid 29239427)
7. Nakamoto Y, Osman M, Wahl RL. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Clin Nucl Med 2003; 28: 302-7. doi: 10.1097/01.RLU.0000057556.54046.7A (Pubitemid 38281949)
8. 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. J Nucl Med 2007; 48: 889-95. doi: 10.2967/jnumed.106.039479
9. 18F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001; 42: 1800-4.
10. Schirrmeister H, Guhlnamm A, Kotzerke J, Santjohanser C, Kühn T, Kreienberg R, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 1999; 17: 2381-9. (Pubitemid 29368236)
11. 18F FDG PET/CT for detection of skeletal metastases. Mol Imaging Biol 2012; 14: 252-9.
12. Yen RF, Chen CY, Cheng MF, Wu YW, Shiau YC, Wu K, et al. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Nucl Med Commun 2010; 31: 637-45. doi: 10.1097/MNM.0b013e3283399120
13. 18F-fluoride PET/CT. J Nucl Med 2006; 47: 287-97.
14. 18F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP. Nucl Med Biol 2013; 40: 518-23. doi: 10.1016/j.nucmedbio.2013.02.009
15. Krasnow AZ, Hellman RS, Timins ME, Collier BD, Anderson T, Isitman AT. Diagnostic bone scanning in oncology. Semin Nucl Med 1997; 27: 107-41. (Pubitemid 27194758)
16. 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 2009; 36: 1807-12. doi: 10.1007/s00259-009-1181-2
17. Nakai T, Okuyama C, Kubota T, Yamada K, Ushijima Y, Taniike K, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 2005; 32: 1253-8. doi: 10.1007/s00259-005-1842-8 (Pubitemid 41598715)
18. 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 2005; 19: 573-9.